Summary
  • Multi-target molecules 197
  • Clinical molecules 0
  • Avg pChEMBL 7.1
Top Co-occurrence Targets
Active Molecules (197)
InChIKey pChEMBL Type Targets Clinical
JHNYAIWXEJSBGF 6.9 Ki 2
ZBWCAPBPHSAJFD 6.9 IC50 2
CUEGVRNFVNRCFT 6.9 Ki 2
CVJBJRQQYWUAPJ 6.9 IC50 2
KFGXONJZGIXSGH 6.8 IC50 2
KEGCOZYNPKOENI 6.8 Ki 2
PVXINZLXDUDSLJ 6.8 Ki 2
WQYWUTMBHBBLCS 6.8 IC50 2
AKZKTNZCQWEVFQ 6.8 Ki 2
UIXRRGFIAVPQEF 6.8 IC50 2
UJNIZUGKDDYPEP 6.8 Ki 2
OYXVEGKFFGZMOT 6.8 Ki 2
UOCKRIUAKQUEKQ 6.7 Ki 2
PKMUHQIDVVOXHQ 6.7 IC50 2
NLGZYIOUBQCYSZ 6.7 Ki 2
IGVYCVBUHQMNRZ 6.7 IC50 2
UKSIDTWNLGQRED 6.7 Ki 2
VGAAKAWUEJYBSO 6.6 Ki 2
HKNJCUVSQUGVHP 6.6 Ki 2
CHRXGLBKPPPZDY 6.6 Ki 2
ZSDMEQDHYASRTO 6.6 IC50 2
JVLIBXIZJUCZPD 6.6 Ki 2
LQCVZCCEYLDBQM 6.5 Ki 2
PUDFTLRNHLQJHN 6.5 IC50 2
PLMXOHHVTRBRNY 6.5 Ki 2
CLVRPAZDBOBROH 6.5 Ki 2
GDKLDALGJZVEKT 6.5 IC50 2
QBPGYDYJTIUYEC 6.5 Ki 2
ONHLDSBQCBVYJW 6.5 IC50 2
RYGJIKURQDMMQZ 6.5 IC50 2
IGVYCVBUHQMNRZ 6.5 IC50 2
JZRRCGQQCZGHEA 6.5 IC50 2
IGVYCVBUHQMNRZ 6.4 IC50 2
ZTKSBNLNPMUGBL 6.4 IC50 2
NBUBKDAZNOWKCZ 6.4 Ki 2
QRCHFFNDYYKHQM 6.3 IC50 2
QXFHJCBKHQAQDM 6.3 IC50 2
AGTLZKXDTWTAOI 6.3 Ki 2
IGVYCVBUHQMNRZ 6.3 IC50 2
VMIGFUOVZDKJCW 6.3 IC50 2
FNMVXLLBGRHAGL 6.3 Ki 2
AFIGPZIBKOZOTH 6.3 IC50 2
APIGQOKYEQLSCD 6.3 IC50 2
AZZBKLHFPZCCEI 6.3 IC50 2
BMWBZSVMPUUEBE 6.3 IC50 2
CFSUUGFQMDKAMH 6.3 IC50 2
CMRWLYLCXJHAMP 6.3 IC50 2
CNIYVBIDLPCYPG 6.3 IC50 2
GNRXUQBCSQURSC 6.3 IC50 2
GTLDPUSOCDSHIU 6.3 IC50 2
2D structure